Astrazeneca (AZN) Income After Tax (2009 - 2026)
Astrazeneca (AZN) reported Income After Tax of $4.8 billion for Q3 2026, up 21.4% from $3.95 billion a year earlier and up 91.4% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Income After Tax (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Astrazeneca's Income After Tax came in at $14.98 billion, up 23.7% year-over-year; for FY2025, it came in at $10.23 billion, up 45.3% from FY2024.
- Income After Tax has a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
- By year, Income After Tax came in at $7.04 billion in FY2024 (-10.9%), $7.9 billion in FY2023 (+139.9%), $3.29 billion in FY2022 and $115 million in FY2021 (-96.3%).
- The Q3 2026 figure ranks as the highest quarterly Income After Tax since Q4 2014.
- Year over year, Income After Tax has now increased in each of the last 15 quarters, with growth averaging 43.0% over the last eight quarters.
- The high point for year-over-year Income After Tax in five years was Q3 2023 (growth of 853.5%); the low point was Q1 2022 (a decline of 56.6%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $2.51 billion (Q2 2026), $4.75 billion (Q1 2026) and $2.93 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 653.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.80 Bn |
| Jun 30, 2026 | 2.51 Bn |
| Mar 31, 2026 | 4.75 Bn |
| Dec 31, 2025 | 2.93 Bn |
| Sep 30, 2025 | 3.95 Bn |
| Jun 30, 2025 | 2.45 Bn |
| Mar 31, 2025 | 3.88 Bn |
| Dec 31, 2024 | 1.83 Bn |
| Sep 30, 2024 | 2.22 Bn |
| Jun 30, 2024 | 1.93 Bn |
| Mar 31, 2024 | 3.42 Bn |
| Dec 31, 2023 | 835.00 Mn |
| Sep 30, 2023 | 1.93 Bn |
| Jun 30, 2023 | 1.82 Bn |
| Mar 31, 2023 | 2.72 Bn |
| Dec 31, 2022 | 654.00 Mn |
| Sep 30, 2022 | 202.00 Mn |
| Jun 30, 2022 | 360.00 Mn |
| Mar 31, 2022 | 718.00 Mn |
| Dec 31, 2021 | -926.00 Mn |
API Access
Astrazeneca Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();